Skip to main content
Hofseth BioCare ASA logo

Hofseth BioCare ASA — Investor Relations & Filings

Ticker · HBC ISIN · NO0010598683 LEI · 5967007LIEEXZXGGEO44 OL Manufacturing
Open in API
Filings indexed 733 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country NO Norway
Listing OL HBC

About Hofseth BioCare ASA

https://hofsethbiocare.no/

Hofseth BioCare ASA is a biotechnology company that develops and manufactures high-value nutritional ingredients from fresh Norwegian salmon off-cuts. Using a proprietary and patent-protected enzymatic hydrolysis process, the company gently extracts bioactive components, ensuring the preservation of their nutritional value. Its core products include soluble proteins (peptides), full-spectrum salmon oil, and marine calcium/collagen. These ingredients are utilized in clinically-proven finished products for both human nutrition and pet health markets, reflecting a commitment to sustainability and the full utilization of marine resources.

Recent filings

Filing Released Lang Actions
Hofseth BioCare ASA: EXCLUSIVE LICENSE AND SUPPLY AGREEMENT SIGNED FOR PROGO FOR OVER $5M
Regulatory Filings Classification · 63% confidence The document is a stock exchange announcement by Hofseth BioCare ASA disclosing an exclusive license and supply agreement. It contains no financial results, management discussion, meeting materials, or capital-raising details. It is an obligatory disclosure of inside information under MAR, i.e. a general regulatory announcement. There is no specific category for commercial agreements, so it falls under the fallback “Regulatory Filings (RNS)”.
2026-05-22 English
Financial calendar
Regulatory Filings
2026-05-06 Norwegian
Hofseth BioCare ASA: HBC publishes paradigm-changing clinical trial results of OmeGo full spectrum omegas
Regulatory Filings Classification · 20% confidence The document is a press‐style announcement of clinical trial results for a product (OmeGo). It does not present actual financial results, regulatory filings (like a 10‐K or interim report), board changes, or capital updates. It is not a presentation deck or data supplement. It most closely fits our fallback “General Regulatory Filings” category for miscellaneous corporate announcements (RNS).
2026-04-14 English
Hofseth BioCare ASA: HBC ANNUAL REPORT 2025 - Attachment: hofsethbiocareasa-2025-12-31-1-en.zip
Annual Report Classification · 100% confidence The document contains detailed sections typical of a comprehensive yearly corporate filing: corporate governance report, board of directors' report, full financial statements (including income statement, balance sheet, cash flows, changes in equity, notes), declaration by the board and CEO, and auditor's report. It explicitly states 'Annual Report 2025' multiple times and includes extensive financial and governance information. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or summary. There is no indication that this is merely an announcement or a certification letter. Therefore, this document fits the definition of an Annual Report (10-K). FY 2025
2026-03-27 English
Hofseth BioCare ASA: HBC ANNUAL REPORT 2025 - Attachment: Hofseth Biocare 2025 ESG report.pdf
Environmental & Social Information Classification · 95% confidence The document is a standalone ESG report titled “ESG REPORT 2025” covering Governance, Environment, and Social topics. It follows GRI standards and focuses on the company’s sustainability performance, GHG emissions, resource use, social commitments, and governance structures. This matches the Environmental & Social Information category.
2026-03-27 English
Hofseth BioCare ASA: HBC ANNUAL REPORT 2025 - Attachment: Hofseth Biocare 2025 Annual report.pdf
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2025' and contains detailed sections typical of an annual report, including corporate governance, the board of directors' report, comprehensive financial statements (income statement, financial position, cash flows, changes in equity), notes to the accounts, declaration by the board and CEO, and the auditor's report. The content covers the full scope of company activity and financial performance for the fiscal year 2025. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is the full annual report, not just an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K).
2026-03-27 Norwegian

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.